Akt Cancer Research Results
Akt, PKB-Protein kinase B: Click to Expand ⟱
| Source: HalifaxProj(inhibit) |
| Type: |
Akt1 is involved in cellular survival pathways, by inhibiting apoptotic processes; Akt2 is an important signaling molecule in the insulin signaling pathway. It is required to induce glucose transport.
Inhibitors:
-Curcumin: downregulate AKT phosphorylation and signaling.
-Resveratrol
-Quercetin: inhibit the PI3K/AKT pathway.
-Epigallocatechin Gallate (EGCG)
-Luteolin and Apigenin: inhibit AKT phosphorylation
|
Cerv, Cervical Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
ROS↑, Casp3↑, Casp9↑, Casp6↑, GSH↓, SOD↓, GPx↓, MMP↓, P53↑, P21↑, Cyt‑c↑, BID↑, BAX↑, Bcl-2↓, Bcl-xL↓, Akt↓, Raf↓, ERK↓, MAP2K1/MEK1↓, JNK↑, p38↑,
PI3K↓, p‑Akt↓, ROS↑, TumCCA↑, p27/CDKN1B↑, P21↑, mt-Apoptosis↑, BAD↑, Casp9↑, MMP↓, eff↓,
tumCV↓, BAX↑, BID↑, BOK↑, APAF1↑, TNF-α↑, FasL↑, Fas↑, FADD↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, Mcl-1↓, NAIP↓, Bcl-2↓, CDK4↓, CycB/CCNB1↓, cycD1/CCND1↓, cycE1↓, TRAIL↑, p‑Akt↓, Akt↓, mTOR↓, PDK1 / PDPK1↓, BAD↓, GSK‐3β↑, AMPK↑, p27/CDKN1B↑, P53↑,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Nor, |
HUVECs |
|
|
|
eff↑, Dose∅, *BioAv↑, selectivity↑, TumCP↓, Casp↑, PTEN↑, TSC1↑, mTOR⇅, Akt↓, PDK1 / PDPK1↓, E6↓, E7↓, DNAdam↑, ROS↑, *BioAv↓, *BioEnh↑, *Half-Life∅,
TumCCA↑, STAT3↓, P21↑, IGFBP7↑, Akt↓, mTOR↓, ROS↑, DNAdam↑, P53↑, P21↑, BAX↑,
p‑Akt↓, Apoptosis↑, TumCG↓, Dose↝, PI3K↓, eff↑, ATP↓, OCR↓, TumCCA↑, IGF-1↓, angioG↓, TumCI↓,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Cerv, |
HTB-35 |
|
|
|
tumCV↓, TumCP↓, ADAM17↓, EGFR↓, p‑Akt↓, p‑ERK↓,
NF-kB↓, Akt↓, MMP↓, Cyt‑c↑, Apoptosis↑, Casp3↑, Casp9↑, PARP↑, eff↑,
*antiOx↑, *AntiTum↑, Apoptosis↑, TumCD↑, tumCV↓, PI3K↓, Akt↓, hTERT/TERT↓,
*antiOx↑, *Inflam↓, tumCV↓, TumCMig↓, TumAuto↑, p‑PI3K↓, p‑Akt↓, p‑mTOR↓, Apoptosis↑, PI3K↓, Akt↓, mTOR↓,
ChemoSen↑, TumCP↓, vinculin↓, TumCA↓, TumCMig↓, TumCI↓, p‑Akt↓, p‑PI3K↓, mTOR↓, E-cadherin↑, β-catenin/ZEB1↑, Snail↓, Slug↓,
tumCV↓, TumAuto↑, Casp3↑, BAX↑, Beclin-1/ATG6↑, ATG3↑, ATG5↑, Bcl-2↓, mTOR↓, PI3K↓, Akt↓, PTEN↑, ROS↑, MMP↓,
TumCP↓, PI3K↓, Akt↓, mTOR↓, eff↑, ROS↑,
| - |
in-vivo, |
Cerv, |
HeLa |
|
|
|
- |
in-vivo, |
Cerv, |
SiHa |
|
|
|
TumCG↓, toxicity↓, tumCV↓, Apoptosis↑, p‑PI3K↓, p‑Akt↓, eff↑,
Showing Research Papers: 1 to 14 of 14
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 14
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
GPx↓, 1, GSH↓, 1, ROS↑, 6, SOD↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
ATP↓, 1, BOK↑, 1, MMP↓, 4, OCR↓, 1, Raf↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 1, PDK1 / PDPK1↓, 2,
Cell Death(tgid=5) ⓘ
Akt↓, 9, p‑Akt↓, 7, APAF1↑, 1, Apoptosis↑, 5, mt-Apoptosis↑, 1, BAD↓, 1, BAD↑, 1, BAX↑, 4, Bcl-2↓, 3, Bcl-xL↓, 1, BID↑, 2, Casp↑, 1, Casp3↑, 4, Casp6↑, 1, Casp7↑, 1, Casp8↑, 1, Casp9↑, 4, Cyt‑c↑, 2, FADD↑, 1, Fas↑, 1, FasL↑, 1, hTERT/TERT↓, 1, JNK↑, 1, Mcl-1↓, 1, NAIP↓, 1, p27/CDKN1B↑, 2, p38↑, 1, TRAIL↑, 1, TumCD↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 6,
Autophagy & Lysosomes(tgid=9) ⓘ
ATG3↑, 1, ATG5↑, 1, Beclin-1/ATG6↑, 1, TumAuto↑, 2,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 2, P53↑, 3, PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK4↓, 1, CycB/CCNB1↓, 1, cycD1/CCND1↓, 1, cycE1↓, 1, P21↑, 4, TumCCA↑, 3,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
ERK↓, 1, p‑ERK↓, 1, GSK‐3β↑, 1, IGF-1↓, 1, IGFBP7↑, 1, MAP2K1/MEK1↓, 1, mTOR↓, 6, mTOR⇅, 1, p‑mTOR↓, 1, PI3K↓, 6, p‑PI3K↓, 3, PTEN↑, 2, STAT3↓, 1, TumCG↓, 2,
Migration(tgid=13) ⓘ
E-cadherin↑, 1, Slug↓, 1, Snail↓, 1, TSC1↑, 1, TumCA↓, 1, TumCI↓, 2, TumCMig↓, 2, TumCP↓, 4, vinculin↓, 1, β-catenin/ZEB1↑, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, EGFR↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
NF-kB↓, 1, TNF-α↑, 1,
Cellular Microenvironment(tgid=17) ⓘ
ADAM17↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1, Dose↝, 1, Dose∅, 1, eff↓, 1, eff↑, 5, selectivity↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
E6↓, 1, E7↓, 1, EGFR↓, 1, hTERT/TERT↓, 1,
Functional Outcomes(tgid=23) ⓘ
toxicity↓, 1,
Total Targets: 94
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 2,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv↑, 1, BioEnh↑, 1, Half-Life∅, 1,
Functional Outcomes(tgid=23) ⓘ
AntiTum↑, 1,
Total Targets: 7
Scientific Paper Hit Count for: Akt, PKB-Protein kinase B
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:29 Cells:% prod#:% Target#:4 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page